Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Vox Sanguinis International Forum on the use of prehospital blood products and pharmaceuticals in the treatment of patients with traumatic haemorrhage

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Epidemiology of chronic red-cell transfusion recipients in Sweden and Denmark-a 10 year follow-up study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Thirty-three-day storage of dithiothreitol-treated red blood cells used to eliminate daratumumab interference in serological testing

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Iron deficiency and preoperative anaemia in patients scheduled for elective hip- and knee arthroplasty - an observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Platelet increment is not associated with endothelial damage in haematological patients: a prospective observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Storage time of red blood cells among ICU patients with septic shock

    Research output: Contribution to journalJournal articleResearchpeer-review

  • M H Yazer
  • P C Spinella
  • S Allard
  • D Roxby
  • C So-Osman
  • M Lozano
  • K Gunn
  • A W-Y Shih
  • J Stensballe
  • P I Johansson
  • M Bagge Hansen
  • M Maegele
  • H Doughty
  • N Crombie
  • D H Jenkins
  • A McGinity
  • R M Schaefer
  • C Martinaud
  • E Shinar
  • R Strugo
  • J Chen
  • H Russcher
View graph of relations

While specific practices and transported blood products vary around the world, most of the respondents in this International Forum transported at least one blood product for the transfusion to bleeding patients en route to the hospital. The most commonly carried product was RBCs, while the use of whole blood will likely increase given the recent reports of its successful use in the civilian setting, and because of the change in the AABB's Standards regulating its use. It will be interesting to see if plasma use in the prehospital setting becomes more widely used given today's enhanced appreciated of the coagulopathy of trauma and plasma's beneficial effect in reversing it, and if blood products are transported to the scene of injury by more vehicles, that is, not just predominantly in helicopters. It was not surprising that TXA is being widely administered as close to the time of injury as possible given its potential benefit in these patients. This International Forum highlights the importance of focusing attention on prehospital transfusion management with a need to further high‐quality research in this area to guide optimal resuscitation strategies.

Original languageEnglish
JournalVox Sanguinis
Volume113
Issue number7
Pages (from-to)701-706
Number of pages6
ISSN0042-9007
DOIs
Publication statusPublished - Oct 2018

    Research areas

  • Blood Substitutes/therapeutic use, Blood Transfusion/methods, Congresses as Topic, Emergency Medical Services/methods, Hemorrhage/therapy, Humans

ID: 56762947